Geode Capital Management
BNTX icon

Geode Capital Management’s BioNTech BNTX Stock Holding History

Geode Capital Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.3M Buy
142,852
+5,432
+4% +$511K ﹤0.01% 2388
2026
Q1 		$12.2M Buy
137,420
+16,815
+14% +$1.73M ﹤0.01% 2269
2025
Q4 		$11.5M Buy
120,605
+4,615
+4% +$465K ﹤0.01% 2345
2025
Q3 		$11.4M Buy
115,990
+12,240
+12% +$1.31M ﹤0.01% 2340
2025
Q2 		$11M Buy
103,750
+2,402
+2% +$243K ﹤0.01% 2297
2025
Q1 		$9.23M Sell
101,348
-367
-0.4% -$41.1K ﹤0.01% 2341
2024
Q4 		$11.6M Buy
101,715
+1,063
+1% +$121K ﹤0.01% 2273
2024
Q3 		$12M Sell
100,652
-847
-0.8% -$77.9K ﹤0.01% 2273
2024
Q2 		$8.16M Buy
101,499
+9,089
+10% +$831K ﹤0.01% 2450
2024
Q1 		$8.52M Buy
92,410
+1,983
+2% +$190K ﹤0.01% 2417
2023
Q4 		$9.54M Buy
90,427
+2,362
+3% +$238K ﹤0.01% 2373
2023
Q3 		$9.57M Buy
88,065
+1,245
+1% +$138K ﹤0.01% 2297
2023
Q2 		$9.37M Buy
86,820
+2,508
+3% +$282K ﹤0.01% 2323
2023
Q1 		$10.5M Buy
84,312
+980
+1% +$135K ﹤0.01% 2227
2022
Q4 		$12.5M Buy
83,332
+3,870
+5% +$596K ﹤0.01% 2100
2022
Q3 		$10.7M Buy
79,462
+2,172
+3% +$332K ﹤0.01% 2195
2022
Q2 		$11.5M Buy
77,290
+11,250
+17% +$1.72M ﹤0.01% 2150
2022
Q1 		$11.3M Buy
66,040
+158
+0.2% +$26.5K ﹤0.01% 2273
2021
Q4 		$17M Buy
65,882
+6,958
+12% +$1.91M ﹤0.01% 2068
2021
Q3 		$16.1M Buy
58,924
+1,860
+3% +$591K ﹤0.01% 2108
2021
Q2 		$12.8M Buy
57,064
+1,304
+2% +$246K ﹤0.01% 2289
2021
Q1 		$6.09M Buy
55,760
+7,635
+16% +$811K ﹤0.01% 2688
2020
Q4 		$3.92M Buy
48,125
+8,178
+20% +$803K ﹤0.01% 2723
2020
Q3 		$2.77M Buy
39,947
+33,361
+507% +$2.39M ﹤0.01% 2706
2020
Q2 		$439K Buy
6,586
+540
+9% +$27K ﹤0.01% 3422
2020
Q1 		$353K Buy
+6,046
New +$235K ﹤0.01% 3372

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
GP
GSK plc London $602M AUM

Geode Capital Management's BNTX Position: Q2 2026 in Review

Geode Capital Management increased its BioNTech (BNTX) stake by 4% in Q2 2026, buying an estimated $511K and bringing the position to 142,852 shares worth $13.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2388.

Geode Capital Management first reported a position in BNTX in Q1 2020 and has held it in 26 quarters since. The position peaked at $17M in Q4 2021. 283 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • Geode Capital Management held 142,852 shares of BioNTech worth $13.3M as of Q2 2026.
  • Geode Capital Management bought 5,432 BioNTech shares in Q2 2026, an estimated $511K.
  • BioNTech made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2388 holding.
  • Geode Capital Management first reported a position in BioNTech in Q1 2020 and has held it in 26 quarters since.
  • Geode Capital Management's BioNTech position peaked at $17M in Q4 2021.
  • 283 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.